Related Experiment Video
Updated: May 23, 2026

Analysis of SCAP N-glycosylation and Trafficking in Human Cells
Published on: November 8, 2016
METTL16 Promotes Head and Neck Squamous Cell Carcinoma Progression via m6A-Mediated Stabilization of SREBP2 mRNA and
Xinrui Ma1, Xiaojun Ding1, Jianhua Deng1
1Department of Otolaryngology, Head and Neck Surgery, The First People's Hospital of Kunshan, Jiangsu, China.
Abstract:
N6-methyladenosine (m6A) modification is a crucial epigenetic event in the development of head and neck squamous cell carcinoma (HNSCC). Here, we show that methyltransferase-like 16 (METTL16) expression is elevated in the tumor tissues of patients with HNSCC and is associated with poor prognosis. In addition, our data show that METTL16 promotes the proliferation of HNSCC cells in vitro and in vivo by enhancing cholesterol biosynthesis. Mechanistically, METTL16 catalyzes a key transcription factor in cholesterol biosynthesis-sterol regulatory element-binding transcription factor 2 (SREBP2) m6A modification and then stabilizes SREBP2 mRNA and ultimately elevates SREBP2 mRNA expression in HNSCC cells. Moreover, we validate that METTL16 promotes HNSCC progression dependent on SREBP2 mRNA expression. Overall, our results reveal a novel function of METTL16 in regulating SREBP2 expression, revealing a previously unrecognized METTL16/SREBP2 pathway in HNSCC cells.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Nuclear Protein Sorting
Abnormal Proliferation
Master Transcription Regulators
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...